Chemists create quantum dots at room temperature using lab-designed protein

Ireland News News

Chemists create quantum dots at room temperature using lab-designed protein
Ireland Latest News,Ireland Headlines
  • 📰 physorg_com
  • ⏱ Reading Time:
  • 27 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 55%

Chemists create quantumdots at room temperature using lab-designed protein princeton PNASNews

. Quantum dots are fluorescent nanocrystals used in electronic applications from LED screens to solar panels.

"We're interested in making life molecules, proteins, that did not arise in life," said Hecht, who led the research with Greg Scholes, the William S. Tod Professor of Chemistry and chair of the department."In some ways we're asking, are there alternatives to life as we know it? All life on earth arose from common ancestry.

"But on the other hand, they're also very good at emitting light at a certain desired wavelength, which makes them suitable for making LED screens."

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

physorg_com /  🏆 388. in US

Ireland Latest News, Ireland Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial - Nature MedicineTisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial - Nature MedicineIn a prespecified interim analysis of a pivotal phase 2 trial, tisagenlecleucel, an autologous CD19-targeting CAR-T cell therapy, produced a high rate of complete responses with a manageable safety profile in adults with relapsed or refractory follicular lymphoma
Read more »

Activists dressed as birds and trees rally for nature at COP15 in MontrealActivists dressed as birds and trees rally for nature at COP15 in MontrealHundreds of people on Saturday braved sub-zero temperatures to march the streets of Montreal, the host city of this year's U.N. biodiversity summit, demanding a strong new deal to protect nature worldwide.
Read more »

Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial - Nature MedicineSafety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial - Nature MedicinePresented at ASH21: In the phase 1 EXPLORER trial, avapritinib, a selective KIT inhibitor, was generally well tolerated and elicited durable clinical and molecular responses in patients with advanced systemic mastocytosis MPNsm ASH22
Read more »

Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells - Nature MedicineAntigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells - Nature MedicineA bedside-to-bench analysis identifies single-chain variable fragment linker length as an important component of chimeric antigen receptor (CAR) structure and suggests that, in contrast to CD28-based CAR T cells, tonic signaling can be beneficial for 4-1BB-based CAR T cell function.
Read more »

Explainer: U.N. nature summit puts industry on alert to disclose moreExplainer: U.N. nature summit puts industry on alert to disclose moreIndustry executives have joined activists and negotiators from nearly 200 countries at this month's U.N. nature summit in Montreal, where negotiations on a global pact to protect nature could lead to tougher disclosure requirements for businesses.
Read more »

Investor group launches campaign to help companies protect natureInvestor group launches campaign to help companies protect natureHere's the plan: Select 100 companies whose business burdens nature. Then, offer advice on how to lighten their impact and monitor their progress.
Read more »



Render Time: 2025-03-03 14:52:06